Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors
Ibrutinib (IBR) is an irreversible inhibitor of Bruton tyrosine kinase (Btk) that is approved for the treatment of...